Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark; 2Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Denmark; 3Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark; 4Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 5Centre for Health Sciences Education, Aarhus University, Aarhus, Denmark; 6Research Centre for Prevention and Health, Department 84-85, Glostrup University Hospital, Glostrup, Denmark; 7Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Список исп. литературыСкрыть список 1. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol 2014;10:425-48. 2. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 2014;13:153-60. 3. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013;346:f2539. 4. Nordentoft M, Wahlbeck K, Hallgren J et al. Excess mortality, causes of € death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013;8:e55176. 5. Andreassen OA, Djurovic S, Thompson WK et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013;92:197-209. 6. Daumit GL, Goff DC, Meyer JM et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 2008;105:175-87. 7. Correll CU, Detraux J, De Lepeleire J et al. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14: 119-36. 8. Laursen TM, Nordentoft M. Heart disease treatment and mortality in schizophrenia and bipolar disorder 2 changes in the Danish population between 1994 and 2006. J Psychiatr Res 2011;45:29-35. 9. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Br J Psychiatry 2003;183:534-9. 10. Bak M, Fransen A, Janssen J et al. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 2014;9:10-2. 11. Correll CU, Joffe BI, Rosen LM et al. Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study. World Psychiatry 2015;14:56- 63. 12. Daumit GL, Dickerson FB, Wang N-Y et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 2013;368: 1594-602. 13. Bartels SJ, Pratt SI, Aschbrenner KA et al. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 2013;64:729-36. 14. Green CA, Yarborough BJH, Leo MC et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry 2015;172:71-81. 15. Ross R, Blair S, de Lannoy L et al. Changing the endpoints for determining effective obesity management. Prog Cardiovasc Dis 2015;57: 330-6. 16. Thomsen TF, Davidsen M, Ibsen H et al. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD(R) and the Copenhagen Risk Score. Eur J Cardiovasc Prev Rehabil 2001;8:291-7. 17. McGinty EE, Baller J, Azrin ST et al. Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull 2016;42:96-124. 18. Bruins J, Jorg F, Bruggeman R et al. The effects of lifestyle interventions on € (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PLoS One 2014;9:e112276. 19. Vink RG, Roumans NJT, Arkenbosch LAJ et al. The effect of rate of weight loss on long-term weight regain in adults with overweight and obesity. Obesity 2016;24:321-7. 20. Bartels SJ, Pratt SI, Aschbrenner KA et al. Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry 2015;172:344-52. 21. Speyer H, Norgaard HCB, Hjorthoj C et al. Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity. BMC Psychiatry 2015;15:119. 22. Wing JK, Sartorius N, Ustun TB. Diagnosis and clinical measurement in psychiatry: a reference manual for SCAN. Cambridge: Cambridge University Press, 1998. 23. World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva: World Health Organization, 2008. 24. Jørgensen T, Borch-Johnsen K, Thomsen TF et al. A randomized nonpharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003;10:377- 86. 25. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992;28:183-218. 26. Miller WR, Rollnick S. The effectiveness and ineffectiveness of complex behavioral interventions: impact of treatment fidelity. Contemp Clin Trials 2014;37:234-41. 27. Stein LI, Test MA. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry 1980;37:392-7. 28. Danish Cancer Society. Manual til Rygeafvænning Gruppe. www.cancer.dk. 29. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10. 30. Andersen LG, Groenvold M, Jørgensen T et al. Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing. Scand J Public Health 2010;38:707-14. 31. Heatherton TF, Kozlowski LT, Frecker RC et al. The Fagerstrom Test for € Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Addiction 1991;86:1119-27. 32. Toft U, Kristoffersen LH, Lau C et al. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur J Clin Nutr 2007;61:270-8. 33. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa, 1984. 34. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1984. 35. Keefe RSE, Goldberg TE, Harvey PD et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004;68:283-97. 36. Bjorkman T, Svensson B. Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA). Nord J Psychiatry 2005;59:302-6. 37. Luo N, Johnson JA, Shaw JW et al. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005;43:1078-86. 38. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning - Split version. Compr Psychiatry 2007;48:88-94. 39. Mossey JM, Shapiro E. Self-rated health: a predictor of mortality among the elderly. Am J Publ Health 1982;72:800-8. 40. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96. 41. Druss BG, Zhao L, von Esenwein SA et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res 2010;118: 264-70. 42. Saidj M, Jørgensen T, Prescott E et al. Poor predictive ability of the risk chart SCORE in a Danish population. Dan Med J 2013;60:A4609. 43. Scheewe TW, Backx FJG, Takken T et al. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand 2013;127:464-73. 44. Kimhy D, Vakhrusheva J, Bartels MN et al. The impact of aerobic exercise on brain-derived neurotrophic factor and neurocognition in individuals with schizophrenia: a single-blind, randomized clinical trial. Schizophr Bull 2015;41:859-68. 45. Pajonk F, Wobrock T. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry 2010;67:133-43. 46. McKibbin CL, Patterson TL, Norman G et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006;86:36-44. 47. Wu M-K, Wang C-K, Bai Y-M et al. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv 2007;58:544-50. 48. Alvarez-Jimenez M, Martinez-Garcia O, Perez-Iglesias R et al. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res 2010;116:16-9. 49. Cordes J, Thunker J, Regenbrecht G et al. Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48- week results from a 6-month randomized trial. World J Biol Psychiatry 2014;15:229-41. 50. Methapatara W, Srisurapanont M. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial. Psychiatry Clin Neurosci 2011;65:374-80. 51. Lovell K, Wearden A, Bradshaw T et al. An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study. J Clin Psychiatry 2014;75:498-505. 52. Attux C, Martini LC, Elkis H et al. A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry 2013;13:60. 53. Brar JS, Ganguli R, Pandina G et al. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005;66:205-12. 54. Littrell KH, Hilligoss NM, Kirshner CD et al. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003; 35:237-41. 55. Wu MH, Lee CP, Hsu SC et al. Effectiveness of high-intensity interval training on the mental and physical health of people with chronic schizophrenia. Neuropsychiatr Dis Treat 2015;11:1255-63. 56. Forsberg KA, Bjorkman T, Sandman PO et al. Physical health – a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff. Nord J Psychiatry 2008;62:486-95. 57. Scheewe TW, Backx FJG, Takken T et al. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand 2013;127:464-73. 58. Osbron DPJ, Hardoon S, Omar RZ et al. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry 2015;72: 143-51.